Logo image of CX

CEMEX SAB-SPONS ADR PART CER (CX) Stock Fundamental Analysis

NYSE:CX - New York Stock Exchange, Inc. - US1512908898 - ADR - Currency: USD

5.93  -0.27 (-4.35%)

After market: 5.93 0 (0%)

Fundamental Rating

3

Taking everything into account, CX scores 3 out of 10 in our fundamental rating. CX was compared to 11 industry peers in the Construction Materials industry. CX has a bad profitability rating. Also its financial health evaluation is rather negative. CX is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CX was profitable.
CX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CX reported negative net income in multiple years.
Of the past 5 years CX 4 years had a positive operating cash flow.
CX Yearly Net Income VS EBIT VS OCF VS FCFCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B

1.2 Ratios

CX has a Return On Assets of 2.51%. This is amonst the worse of the industry: CX underperforms 90.91% of its industry peers.
The Return On Equity of CX (5.82%) is worse than 90.91% of its industry peers.
CX has a Return On Invested Capital of 7.79%. This is in the lower half of the industry: CX underperforms 72.73% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CX is significantly below the industry average of 20.57%.
The last Return On Invested Capital (7.79%) for CX is above the 3 year average (6.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.51%
ROE 5.82%
ROIC 7.79%
ROA(3y)2.24%
ROA(5y)0.37%
ROE(3y)5.79%
ROE(5y)0.15%
ROIC(3y)6.67%
ROIC(5y)5.81%
CX Yearly ROA, ROE, ROICCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15

1.3 Margins

CX has a Profit Margin of 3.40%. This is amonst the worse of the industry: CX underperforms 90.91% of its industry peers.
CX's Profit Margin has declined in the last couple of years.
CX has a worse Operating Margin (10.43%) than 90.91% of its industry peers.
In the last couple of years the Operating Margin of CX has remained more or less at the same level.
CX has a Gross Margin of 33.93%. This is in the better half of the industry: CX outperforms 72.73% of its industry peers.
CX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.43%
PM (TTM) 3.4%
GM 33.93%
OM growth 3Y6%
OM growth 5Y-0.54%
PM growth 3YN/A
PM growth 5Y-23.14%
GM growth 3Y1.57%
GM growth 5Y-0.52%
CX Yearly Profit, Operating, Gross MarginsCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CX is destroying value.
There is no outstanding debt for CX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CX Yearly Shares OutstandingCX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CX Yearly Total Debt VS Total AssetsCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

CX has an Altman-Z score of 1.59. This is a bad value and indicates that CX is not financially healthy and even has some risk of bankruptcy.
CX has a Altman-Z score of 1.59. This is in the lower half of the industry: CX underperforms 72.73% of its industry peers.
The Debt to FCF ratio of CX is 11.04, which is on the high side as it means it would take CX, 11.04 years of fcf income to pay off all of its debts.
CX has a worse Debt to FCF ratio (11.04) than 72.73% of its industry peers.
A Debt/Equity ratio of 0.58 indicates that CX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.58, CX is doing worse than 72.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 11.04
Altman-Z 1.59
ROIC/WACC0.63
WACC12.36%
CX Yearly LT Debt VS Equity VS FCFCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.3 Liquidity

CX has a Current Ratio of 0.98. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
CX has a Current ratio of 0.98. This is amonst the worse of the industry: CX underperforms 90.91% of its industry peers.
A Quick Ratio of 0.73 indicates that CX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.73, CX is doing worse than 81.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.73
CX Yearly Current Assets VS Current LiabilitesCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2

3. Growth

3.1 Past

CX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1740.17%, which is quite impressive.
The earnings per share for CX have been decreasing by -21.34% on average. This is quite bad
EPS 1Y (TTM)1740.17%
EPS 3Y-21.34%
EPS 5YN/A
EPS Q2Q%1700%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.18%

3.2 Future

CX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -51.48% yearly.
Based on estimates for the next years, CX will show a small growth in Revenue. The Revenue will grow by 4.14% on average per year.
EPS Next Y-78.42%
EPS Next 2Y-51.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.61%
Revenue Next 2Y2.21%
Revenue Next 3Y1.09%
Revenue Next 5Y4.14%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CX Yearly Revenue VS EstimatesCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50B 100B 150B 200B 250B
CX Yearly EPS VS EstimatesCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 20 -20 -40 -60

7

4. Valuation

4.1 Price/Earnings Ratio

CX is valuated cheaply with a Price/Earnings ratio of 0.56.
Based on the Price/Earnings ratio, CX is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 29.75, CX is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 2.62, the valuation of CX can be described as very cheap.
CX's Price/Forward Earnings ratio is rather cheap when compared to the industry. CX is cheaper than 100.00% of the companies in the same industry.
CX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.56
Fwd PE 2.62
CX Price Earnings VS Forward Price EarningsCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CX is valued cheaper than 90.91% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CX is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.65
EV/EBITDA 4.56
CX Per share dataCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

CX's earnings are expected to decrease with -51.48% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.48%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

CX has a Yearly Dividend Yield of 34.16%, which is a nice return.
Compared to an average industry Dividend Yield of 5.69, CX pays a better dividend. On top of this CX pays more dividend than 100.00% of the companies listed in the same industry.
CX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 34.16%

5.2 History

CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CX Yearly Dividends per shareCX Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y-51.48%
EPS Next 3YN/A
CX Yearly Income VS Free CF VS DividendCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (3/3/2025, 8:24:12 PM)

After market: 5.93 0 (0%)

5.93

-0.27 (-4.35%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)04-28 2025-04-28
Inst Owners26.76%
Inst Owner Change2.85%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.60B
Analysts81.18
Price Target6.18 (4.22%)
Short Float %1.07%
Short Ratio1.56
Dividend
Industry RankSector Rank
Dividend Yield 34.16%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-10 2025-03-10 (0.008271)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-43.37%
Min EPS beat(2)-51.46%
Max EPS beat(2)-35.28%
EPS beat(4)1
Avg EPS beat(4)328.8%
Min EPS beat(4)-148.54%
Max EPS beat(4)1550.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.42%
Min Revenue beat(2)-8.32%
Max Revenue beat(2)-6.51%
Revenue beat(4)0
Avg Revenue beat(4)-5.36%
Min Revenue beat(4)-8.32%
Max Revenue beat(4)-2%
Revenue beat(8)1
Avg Revenue beat(8)-3.46%
Revenue beat(12)2
Avg Revenue beat(12)3.45%
Revenue beat(16)2
Avg Revenue beat(16)-15.52%
PT rev (1m)0%
PT rev (3m)7.09%
EPS NQ rev (1m)-37.5%
EPS NQ rev (3m)25%
EPS NY rev (1m)0%
EPS NY rev (3m)15%
Revenue NQ rev (1m)-2.41%
Revenue NQ rev (3m)-11.94%
Revenue NY rev (1m)12.16%
Revenue NY rev (3m)-4.66%
Valuation
Industry RankSector Rank
PE 0.56
Fwd PE 2.62
P/S 0.42
P/FCF 12.65
P/OCF 4.34
P/B 0.71
P/tB 3.15
EV/EBITDA 4.56
EPS(TTM)10.5
EY177.07%
EPS(NY)2.27
Fwd EY38.21%
FCF(TTM)0.47
FCFY7.91%
OCF(TTM)1.37
OCFY23.03%
SpS14.27
BVpS8.34
TBVpS1.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.51%
ROE 5.82%
ROCE 9.86%
ROIC 7.79%
ROICexc 8.04%
ROICexgc 14.41%
OM 10.43%
PM (TTM) 3.4%
GM 33.93%
FCFM 3.29%
ROA(3y)2.24%
ROA(5y)0.37%
ROE(3y)5.79%
ROE(5y)0.15%
ROIC(3y)6.67%
ROIC(5y)5.81%
ROICexc(3y)6.93%
ROICexc(5y)6.05%
ROICexgc(3y)12.97%
ROICexgc(5y)11.52%
ROCE(3y)8.44%
ROCE(5y)7.36%
ROICexcg growth 3Y16.73%
ROICexcg growth 5Y6.31%
ROICexc growth 3Y18.38%
ROICexc growth 5Y7.78%
OM growth 3Y6%
OM growth 5Y-0.54%
PM growth 3YN/A
PM growth 5Y-23.14%
GM growth 3Y1.57%
GM growth 5Y-0.52%
F-Score8
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 11.04
Debt/EBITDA 2.06
Cap/Depr 104.06%
Cap/Sales 6.28%
Interest Coverage 250
Cash Conversion 58.11%
Profit Quality 96.65%
Current Ratio 0.98
Quick Ratio 0.73
Altman-Z 1.59
F-Score8
WACC12.36%
ROIC/WACC0.63
Cap/Depr(3y)92.78%
Cap/Depr(5y)78.74%
Cap/Sales(3y)6.81%
Cap/Sales(5y)6%
Profit Quality(3y)234.17%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1740.17%
EPS 3Y-21.34%
EPS 5YN/A
EPS Q2Q%1700%
EPS Next Y-78.42%
EPS Next 2Y-51.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.18%
Revenue Next Year-0.61%
Revenue Next 2Y2.21%
Revenue Next 3Y1.09%
Revenue Next 5Y4.14%
EBIT growth 1Y48.34%
EBIT growth 3Y17.35%
EBIT growth 5Y4.58%
EBIT Next Year62.69%
EBIT Next 3Y21.83%
EBIT Next 5Y13.46%
FCF growth 1Y-7.85%
FCF growth 3Y-1.32%
FCF growth 5Y0.39%
OCF growth 1Y2.33%
OCF growth 3Y10.21%
OCF growth 5Y6.62%